RN

Ramesh Navaladi

Active Director Director DIN 07957277
DIN 07957277 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2019
Shareholding value •••• Premium profile

About Ramesh Navaladi

Data last updated:

Ramesh Navaladi is a Director at Disruptive Health Solutions Private Limited (since 2019) and Director at Fenway Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.81 Cr; the largest is Disruptive Health Solutions Private Limited at ₹15.23 Cr (FY 2022).

DIN 07957277
Primary Designation Director
Industry Pharma
First Appointment 15 Jul 2019
Oldest Company Age 11 yrs
Largest company Disruptive Health Solutions Private Limited · ₹15.23 Cr (FY 2022)
Combined revenue ₹22.81 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20192014₹15.23 Cr (FY 2022)Active
Director09 Jun 20212021₹7.58 Cr (FY 2022)Active

Board colleagues of Ramesh Navaladi

Directorship timeline

Open interactive timeline →
Fenway Pharmaceuticals Private Limited
Disruptive Health Solutions Private Limited
Premium access

Shareholding and investment profile for Ramesh Navaladi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Navaladi

Ramesh Navaladi currently holds 2 directorships: Disruptive Health Solutions Private Limited (Director, since 15 Jul 2019, revenue ₹15.23 Cr (FY 2022)); Fenway Pharmaceuticals Private Limited (Director, since 09 Jun 2021, revenue ₹7.58 Cr (FY 2022)).

Ramesh Navaladi was first appointed on 15 Jul 2019 as Director at Disruptive Health Solutions Private Limited. The most recent appointment on record is 09 Jun 2021 at Fenway Pharmaceuticals Private Limited.

The 2 current companies of Ramesh Navaladi that report revenue have a combined latest revenue of ₹22.81 Cr: Disruptive Health Solutions Private Limited ₹15.23 Cr (FY 2022); Fenway Pharmaceuticals Private Limited ₹7.58 Cr (FY 2022).

The current boards of Ramesh Navaladi's companies include Akshay Navaladi (Disruptive Health Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available